Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe
Advanced Science · 2025
DOI: 10.1002/advs.202507057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Bing-Jun Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou, China. Hauptthemen laut MEDLINE: Glutamine, Amino Acid Transport System ASC, Minor Histocompatibility Antigens, Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Glutamine addiction, as a hallmark of tumor metabolism, drives malignant progression via proliferation, survival, and metastasis. Alanine‐serine‐cysteine transporter 2 (ASCT2), the primary glutamine transporter, is overexpressed in tumors to meet metabolic demands, making it a promising therapeutic target. Accurately monitoring ASCT2‐mediated glutamine uptake is essential for investigating tumor metabolism and developing ASCT2‐targeted therapeutics. However, current methods lack specificity, require laborious sample processing, and do not support real‐time measurements in living systems. To overcome these issues, BLGLN is designed, an innovative bioluminescent reporter system exploiting Staudinger ligation. BLGLN comprises two components: 1) BL568, a caged D‐luciferin derivative protected with 2‐diphenylphosphinobenzoic acid, and 2) AA201, an azide‐modified glutamine mimetic taken up by ASCT2. Once inside, AA201 undergoes Staudinger ligation with membrane‐permeable BL568, releasing D‐luciferin that is converted by luciferase into a bioluminescent signal, allowing real‐time tracking of ASCT2‐dependent glutamine uptake in tumors. BLGLN provides simplified synthesis, eliminates complex sample preparation, and enables real‐time tracking and evaluation of glutamine uptake rate in living tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Normal University, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, Hangzhou Normal University, Hangzhou, China.
- Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, B. J., Zhao, J. L., Yin, F., Chen, W. D., Sun, Y., Ren, Y. Y., Chen, Y. M., Xie, T., Duan, C., & Zhou, J. L. (2025). Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe. Advanced Science. https://doi.org/10.1002/advs.202507057
Vancouver
Zhou BJ, Zhao JL, Yin F, Chen WD, Sun Y, Ren YY, et al. Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe. Advanced Science. 2025. doi:10.1002/advs.202507057
BibTeX
@article{Zhou2025,
author = {Zhou, Bing-Jun and Zhao, Ji-Lei and Yin, Fan and Chen, Wen-Da and Sun, Yi and Ren, Ying-Ying and Chen, Yi-Min and Xie, Tian and Duan, Chong and Zhou, Jian-Liang},
title = {Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202507057}
}
EUVIMED